Semaglutide (brand-name Wegovy and Ozempic) is an FDA-approved GLP-1 receptor agonist used for weight management, treating weight-related complications, and improving glycemic control in patients with type 2 diabetes
The pivotal STEP-1 trial reported approximately 14.9 percent mean body weight loss at 68 weeks on semaglutide
Where it differs structurally as a synthetic peptide is the addition of the amino acid tyrosine at the N-terminus to provide additional stability to the peptide (hence a longer half-life), seen on the top-right corner of the picture below: (Source) Hence why youll also see it labeled as Tyr-hGH Frag 176-191
While no officially approved human dosing exists, community experience and extrapolation from animal research provide useful guidance
If you're vegetarian or vegan, fortified foods are an important source for getting enough B12
When you take something by mouth, your digestive system has to break it down